Alternatives to Veltassa If You Can't Fill Your Prescription

Veltassa (patiromer) is effective at managing hyperkalemia, but it isn't always easy to fill. It's a brand-only drug, costs over $1,000 per month without insurance, and isn't stocked at every pharmacy. If you can't fill your Veltassa prescription — whether due to availability, cost, or insurance problems — there are other options your doctor may consider. Here's what you need to know about Veltassa alternatives in 2026.

First: Don't Stop Your Medication Without Talking to Your Doctor

Before switching medications or stopping altogether, call your doctor's office. Hyperkalemia (high blood potassium) can rise quickly — sometimes within 2 days of stopping Veltassa. Your doctor needs to know you can't fill your prescription so they can either find a solution or prescribe an alternative in the meantime. Never make medication changes on your own for a condition like hyperkalemia.

Alternative #1: Lokelma (Sodium Zirconium Cyclosilicate)

Lokelma is the closest alternative to Veltassa. Approved by the FDA in 2018 and manufactured by AstraZeneca, Lokelma is also a potassium binder taken as a powder mixed with water. The key differences:

Faster onset: Lokelma starts working within 1 hour, compared to about 7 hours for Veltassa. This makes it preferable in hospital or acute care settings.

Sodium content: Lokelma contains sodium, which can cause fluid retention and edema. This is a concern for patients with heart failure or sodium-sensitive conditions. Veltassa does not contain sodium, making it preferred in those cases.

Magnesium: Veltassa can lower magnesium levels (hypomagnesemia), while Lokelma does not typically cause this problem.

Drug separation: Both Lokelma and Veltassa require you to take other oral medications at least 2-3 hours apart to prevent drug binding.

Cost: Lokelma's cash price is roughly $1,000–$1,050 per month — slightly less than Veltassa but still expensive. Both have patient assistance programs.

In clinical trials, nephrologists report similar overall effectiveness between Lokelma and Veltassa, with Lokelma preferred 2:1 for hospitalized patients (due to faster onset) and Veltassa preferred 5:1 for heart failure patients (due to lack of sodium).

Alternative #2: Sodium Polystyrene Sulfonate (Kayexalate / SPS)

Sodium polystyrene sulfonate (SPS) is the oldest potassium-binding medication, FDA-approved since 1958. The brand Kayexalate has been discontinued, but generic SPS is still available. It's significantly cheaper — often under $50 per month — making it more accessible for patients without insurance or with affordability issues.

However, SPS has a less favorable safety and tolerability profile compared to Veltassa:

More gastrointestinal side effects (nausea, vomiting, constipation, rarely intestinal necrosis)

Less predictable and consistent potassium lowering

Contains sodium (similar concern to Lokelma for fluid-sensitive patients)

SPS is generally considered a short-term bridge or last resort when newer agents like Veltassa or Lokelma are unavailable.

Alternative #3: Dietary Potassium Restriction

Dietary changes alone are not a substitute for Veltassa in most patients with significant hyperkalemia, but they can help as a bridge strategy. A low-potassium diet means limiting or avoiding:

Bananas, oranges, avocados, and dried fruits

Potatoes, tomatoes, winter squash, and sweet potatoes

Legumes, nuts, and seeds

Salt substitutes (many contain potassium chloride)

Your doctor or a renal dietitian can provide specific guidance based on your labs and dietary patterns. This approach must be combined with medical supervision.

Alternative #4: Adjust or Temporarily Hold RAAS Inhibitors

Many patients develop hyperkalemia because they are on ACE inhibitors, ARBs, or potassium-sparing diuretics (like spironolactone) — all of which raise potassium. In some cases, your doctor may temporarily reduce or hold these medications while you work on getting Veltassa filled. However, this tradeoff is complex: RAAS inhibitors are often vital for kidney and heart protection. Your doctor will weigh the risks carefully.

Comparing Your Options at a Glance

Veltassa (patiromer): 7-hr onset, once daily, no sodium, may lower magnesium, ~$1,200–$1,500/month cash

Lokelma: 1-hr onset, once daily (after loading doses), contains sodium, may cause edema, ~$1,000–$1,050/month cash

SPS (generic): Onset varies, older drug, more GI side effects, contains sodium, under $50/month — short-term use only

The Bottom Line

If you can't fill Veltassa, Lokelma is the most clinically comparable alternative — your doctor can switch you with a simple prescription change. Older SPS can serve as a budget bridge in a pinch. Before you give up on Veltassa entirely, make sure you've tried locating it at specialty pharmacies or through a service like medfinder. Read our full guide on how to find Veltassa in stock near you for step-by-step help.